Amedisys Inc (AMED) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering AMED.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 12 | $350 | $310 | $331.92 | $260.03 | 27.65% |
The Trend in the Analyst Price Target
AMED's average price target has moved up $51.13 over the prior 152 days.
AMED reports an average of 10.45% for its upside potential over the past 335 days.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-05-08 | 12 | 350 | 310 | 331.92 | 260.13 | 27.6% |
| 2021-04-25 | 12 | 340 | 300 | 327.33 | 284.57 | 15.03% |
| 2021-04-17 | 12 | 340 | 300 | 327.33 | 282.96 | 15.68% |
| 2021-04-10 | 12 | 340 | 300 | 327.33 | 283.09 | 15.63% |
| 2021-04-03 | 12 | 340 | 300 | 329.00 | 269.46 | 22.1% |
| 2021-03-20 | 13 | 340 | 261 | 323.77 | 269.00 | 20.36% |
| 2021-03-13 | 13 | 340 | 261 | 323.77 | 266.30 | 21.58% |
| 2021-03-06 | 13 | 340 | 261 | 323.77 | 241.25 | 34.21% |
| 2021-02-27 | 13 | 340 | 261 | 323.77 | 253.64 | 27.65% |
| 2021-02-20 | 13 | 340 | 261 | 316.69 | 292.48 | 8.28% |
| 2021-02-13 | 13 | 340 | 261 | 316.69 | 308.82 | 2.55% |
| 2021-02-06 | 14 | 340 | 261 | 313.00 | 298.83 | 4.74% |
| 2021-01-30 | 14 | 340 | 261 | 313.00 | 287.31 | 8.94% |
| 2021-01-23 | 14 | 340 | 261 | 309.43 | 313.54 | -1.31% |
| 2021-01-16 | 14 | 340 | 261 | 309.43 | 293.89 | 5.29% |
| 2021-01-09 | 14 | 340 | 261 | 302.14 | 307.07 | -1.61% |
| 2021-01-02 | 14 | 310 | 261 | 283.64 | 293.33 | -3.3% |
| 2020-12-26 | 14 | 310 | 261 | 283.64 | 292.35 | -2.98% |
| 2020-12-19 | 14 | 300 | 261 | 280.79 | 289.80 | -3.11% |
| 2020-12-09 | 14 | 300 | 261 | 280.79 | 262.40 | 7.01% |
| 2020-12-07 | 14 | 300 | 261 | 280.79 | 255.74 | 9.8% |
| 2020-11-15 | 14 | 300 | 261 | 280.79 | 243.43 | 15.35% |
| 2020-11-02 | 14 | 300 | 261 | 280.79 | 254.38 | 10.38% |
| 2020-10-29 | 14 | 300 | 250 | 279.43 | 250.87 | 11.38% |
| 2020-09-17 | 14 | 290 | 245 | 258.29 | 235.14 | 9.85% |
| 2020-09-09 | 14 | 290 | 245 | 257.57 | 230.66 | 11.67% |
| 2020-09-01 | 14 | 290 | 235 | 256.86 | 241.78 | 6.24% |
| 2020-08-19 | 14 | 290 | 235 | 255.43 | 236.17 | 8.16% |
| 2020-07-31 | 13 | 270 | 235 | 252.23 | 234.16 | 7.72% |
| 2020-07-22 | 13 | 260 | 190 | 218.00 | 215.05 | 1.37% |
| 2020-07-16 | 13 | 260 | 190 | 218.00 | 210.42 | 3.6% |
| 2020-07-11 | 13 | 260 | 190 | 214.38 | 207.77 | 3.18% |
| 2020-07-01 | 13 | 240 | 190 | 212.85 | 205.63 | 3.51% |
| 2020-06-17 | 13 | 240 | 190 | 212.85 | 179.88 | 18.33% |
| 2020-06-07 | 13 | 240 | 190 | 212.46 | 175.68 | 20.94% |
AMED Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.42 | 4 | 7 | 2 | 0 | 0 | 13 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- AMED has a higher average analyst price target than 97.37% of all US stocks.
- Amedisys Inc's number of analysts covering the stock is higher than 90.14% of Healthcare stocks.
- Amedisys Inc's variance in analysts' estimates is lower than 83.66% of stocks in the mid market cap category.
- AMED has a greater upside potential (average analyst target price relative to current price) than 25% of Healthcare stocks.
Stocks similar to Amedisys Inc in the Healthcare industry regarding analyst recommendations and price targets are LHCG, LH and NTRA.
Is AMED a Buy, Hold or Sell? See the POWR Ratings now!